Sectors & Industries HealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2026)
Top pharmaceutical stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best pharmaceutical stocks to buy now. Learn More.

Industry: Drug Manufacturers - Spec...

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Pharmaceutical is Zen Rated B and is the 38th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
AMRX	AMNEAL PHARMACEUTICALS INC	$3.72B	-68.00%	2.00%	11.60%	8.60%	-52.97	2.17	36.90%	2.40%	10.75%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$33.03B	20.00%	3.50%	7.93%	9.50%	4.15	1.04	51.80%	8.20%	12.54%
INDV	INDIVIOR PHARMACEUTICALS INC	$3.66B	-99.20%	15.40%	98.95%	80.70%	-13.27	0.71	80.10%	16.90%	22.92%
PAHC	PHIBRO ANIMAL HEALTH CORP	$2.06B	30.80%	6.70%	14.96%	10.10%	3.23	3.05	31.90%	6.30%	11.47%
ELAN	ELANCO ANIMAL HEALTH INC	$11.92B	-3.50%	-1.70%	-0.03%	-0.10%	1.04	2.17	55.00%	-4.90%	-0.08%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$56.33B	1.60%	0.80%	4.45%	7.00%	1.02	1.19	65.30%	2.50%	12.75%
ANIP	ANI PHARMACEUTICALS INC	$1.67B	16.20%	5.60%	9.97%	12.30%	1.66	2.71	61.40%	8.70%	13.11%
HLN	HALEON PLC	$45.08B	10.20%	5.00%	8.67%	24.40%	0.98	0.92	64.20%	15.10%	21.77%
LNTH	LANTHEUS HOLDINGS INC	$4.94B	20.60%	10.80%	17.61%	28.60%	1.04	2.70	61.10%	15.20%	21.64%
KMDA	KAMADA LTD	$490.33M	7.70%	5.40%	7.34%	18.10%	0.41	4.07	42.30%	11.20%	13.48%
IRWD	IRONWOOD PHARMACEUTICALS INC	$495.70M	-8.20%	6.60%	66.44%	16.30%	-2.52	1.13	100.00%	8.10%	34.70%
VTRS	VIATRIS INC	$15.20B	-23.00%	-9.20%	-10.61%	-14.50%	1.53	1.38	35.10%	-24.60%	-22.33%
NBIX	NEUROCRINE BIOSCIENCES INC	$12.81B	16.70%	11.60%	18.14%	20.00%	0.42	3.39	98.20%	16.70%	24.66%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.75B	-3.70%	-2.80%	-4.40%	-15.30%	0.37	1.91	89.60%	-5.40%	-6.82%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$42.33M	-10.50%	-4.00%	-5.74%	-9.90%	2.10	1.01	85.00%	-6.40%	-5.17%
PCRX	PACIRA BIOSCIENCES INC	$951.20M	0.90%	0.50%	3.00%	3.10%	0.83	4.54	79.40%	1.00%	4.72%
BHC	BAUSCH HEALTH COMPANIES INC	$1.86B	-20.50%	0.60%	9.05%	7.80%	-46.91	1.47	70.70%	1.50%	19.56%
ZTS	ZOETIS INC	$48.83B	58.20%	18.10%	27.07%	25.70%	3.64	3.03	71.80%	28.20%	37.84%
ESPR	ESPERION THERAPEUTICS INC	$654.87M	N/A	-6.00%	38.63%	11.90%	-2.54	1.54	67.90%	-5.60%	15.82%
ETON	ETON PHARMACEUTICALS INC	$608.99M	-18.80%	-4.80%	-1.57%	-2.70%	2.52	1.57	53.90%	-5.70%	-1.04%
ORGO	ORGANOGENESIS HOLDINGS INC	$307.45M	7.80%	3.90%	8.96%	12.60%	0.55	3.62	75.60%	3.50%	7.92%
COLL	COLLEGIUM PHARMACEUTICAL INC	$1.13B	24.10%	3.90%	14.38%	19.10%	4.49	1.57	59.30%	8.10%	22.41%
SCYX	SCYNEXIS INC	$41.63M	-19.00%	-14.40%	-15.83%	-21.20%	0.20	7.04	100.00%	-41.80%	-40.95%
LFCR	LIFECORE BIOMEDICAL INC	$150.66M	N/A	N/A	N/A	N/A	-13.95	3.49	N/A	N/A	N/A
AMPH	AMPHASTAR PHARMACEUTICALS INC	$884.72M	12.80%	6.00%	10.14%	11.10%	1.07	4.02	49.50%	13.60%	20.71%
EBS	EMERGENT BIOSOLUTIONS INC	$424.00M	9.60%	3.70%	11.98%	11.50%	1.52	5.01	56.10%	7.10%	19.13%
CRON	CRONOS GROUP INC	$905.93M	-0.90%	-0.80%	-5.54%	-23.60%	0.05	19.59	42.80%	-6.40%	-43.39%
EOLS	EVOLUS INC	$301.88M	N/A	-23.30%	-20.77%	-17.50%	-10.78	1.90	66.30%	-17.40%	-10.52%
CTOR	CITIUS ONCOLOGY INC	$56.76M	-55.20%	-24.00%	-34.19%	-44.40%	0.88	0.83	80.00%	-599.30%	-565.79%
YCBD	CBDMD INC	$7.14M	-64.60%	-34.50%	-26.22%	-97.00%	0.31	2.94	60.60%	-19.50%	-12.37%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.89B	10.20%	5.40%	9.19%	21.60%	0.91	3.11	56.10%	16.90%	27.94%
DERM	JOURNEY MEDICAL CORP	$179.91M	-39.90%	-10.50%	-10.88%	-28.40%	2.29	1.42	70.20%	-14.60%	-8.33%
HROW	HARROW INC	$1.24B	-10.00%	-1.40%	7.52%	10.60%	6.62	2.20	75.10%	-1.90%	8.38%
HCM	HUTCHMED (CHINA) LTD	$2.43B	45.70%	30.20%	36.41%	45.60%	0.41	4.96	38.70%	83.30%	95.42%
PRGO	PERRIGO CO PLC	$1.27B	-35.20%	-14.80%	-15.40%	-18.70%	1.91	2.76	35.10%	-33.50%	-27.24%
ASRT	ASSERTIO HOLDINGS INC	$86.17M	-30.30%	-10.60%	-19.26%	-28.30%	1.84	1.70	70.20%	-25.60%	-22.63%
RGC	REGENCELL BIOSCIENCE HOLDINGS LTD	$13.53B	-54.80%	-50.50%	-70.39%	-83.50%	0.18	7.39	N/A	N/A	N/A
TKNO	ALPHA TEKNOVA INC	$149.51M	-23.30%	-15.80%	-17.17%	-14.40%	0.51	4.58	33.20%	-42.60%	-40.70%
SIGA	SIGA TECHNOLOGIES INC	$353.92M	11.20%	10.00%	15.08%	73.70%	0.10	11.83	68.60%	24.60%	32.12%
ALKS	ALKERMES PLC	$4.69B	14.50%	10.60%	15.63%	27.10%	0.37	3.55	86.70%	16.40%	20.58%
OGI	ORGANIGRAM GLOBAL INC	$183.78M	4.90%	3.30%	1.01%	1.60%	0.44	2.73	35.60%	6.50%	1.57%
RDY	DR REDDYS LABORATORIES LTD	$11.48B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
AQST	AQUESTIVE THERAPEUTICS INC	$485.74M	N/A	-64.50%	-59.11%	-49.80%	-5.77	3.14	58.30%	-188.10%	-149.70%
TLRY	TILRAY BRANDS INC	$723.51M	-114.80%	-87.50%	-120.17%	-196.50%	0.35	2.81	28.00%	-252.20%	-263.98%
EVO	EVOTEC SE	$863.48M	-18.10%	-8.50%	-8.37%	-8.40%	1.22	2.12	10.80%	-21.00%	-15.47%
BIOA	BIOAGE LABS INC	$692.00M	-25.10%	-22.80%	-26.68%	-137.60%	0.10	11.87	100.00%	-1,280.90%	-1,265.29%
CGC	CANOPY GROWTH CORP	$357.08M	-52.90%	-32.70%	-32.28%	-40.00%	0.46	5.34	25.80%	-117.30%	-116.88%
TLPH	TALPHERA INC	$38.83M	-125.80%	-61.60%	-45.00%	-69.20%	0.60	6.83	100.00%	-44,242.90%	-44,242.86%
IXHL	INCANNEX HEALTHCARE INC	$35.71M	-113.30%	-101.90%	-65.84%	-1,772.00%	0.02	48.27	N/A	N/A	N/A
QNTM	QUANTUM BIOPHARMA LTD	$8.55M	-384.90%	-185.60%	-370.55%	-12,582.70%	0.77	1.41	N/A	N/A	N/A
ALVO	ALVOTECH	$1.10B	-26.10%	5.30%	20.46%	10.40%	-8.97	1.42	55.60%	12.10%	39.44%
AKAN	AKANDA CORP	$112.73k	-56.60%	-27.50%	-66.04%	-3,415.80%	0.88	1.26	9.60%	-619.50%	-619.14%
RMTI	ROCKWELL MEDICAL INC	$41.38M	-16.80%	-9.90%	-9.16%	-13.10%	0.55	3.92	15.10%	-7.30%	-5.81%
SXTC	CHINA SXT PHARMACEUTICALS INC	$1.08M	-50.30%	-30.90%	-41.06%	4,390.00%	0.30	4.37	654,226.10%	-4,820,590.80%	-4,550,441.85%
CRDL	CARDIOL THERAPEUTICS INC	$80.98M	-218.50%	-154.20%	-360.16%	733.30%	0.35	3.89	N/A	N/A	N/A
ACB	AURORA CANNABIS INC	$184.87M	-20.60%	-14.00%	-15.21%	-17.60%	0.39	3.06	34.50%	-30.20%	-25.65%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$33.65M	N/A	N/A	N/A	N/A	0.47	1.49	N/A	N/A	N/A
PRFX	PRF TECHNOLOGIES LTD	$917.99k	-127.60%	-57.30%	-47.45%	129.70%	0.32	1.59	N/A	N/A	N/A
IMCC	IM CANNABIS CORP	$2.51M	-86.70%	-9.20%	51.83%	26.60%	10.10	0.82	23.50%	-7.50%	5.81%
INCR	INTERCURE LTD	$36.50M	-15.90%	-9.50%	-6.43%	-8.00%	0.74	1.85	11.40%	-29.20%	-14.54%
ZSTK	ZEROSTACK CORP	$23.43M	-332.00%	-192.10%	-98.25%	-199.70%	0.85	1.01	4.60%	-335.60%	-334.89%
CPHI	CHINA PHARMA HOLDINGS INC	$2.71M	-43.30%	-21.70%	-33.55%	-60.60%	0.90	0.35	-10.90%	-78.70%	-76.02%
BGM	BGM GROUP LTD	$4.34M	-2.40%	-2.10%	-3.78%	-20.90%	0.13	1.82	19.40%	-10.10%	-25.89%
KALA	KALA BIO INC	$1.95M	-2,323.90%	-87.00%	414.59%	-230.60%	-3.89	0.75	N/A	N/A	N/A
UPC	UNIVERSE PHARMACEUTICALS INC	$1.35M	-7.20%	-5.40%	-6.13%	-12.00%	0.24	4.07	35.30%	-20.60%	-19.26%
SBFM	SUNSHINE BIOPHARMA INC	$5.10M	-24.90%	-19.50%	-26.17%	-47.80%	0.30	4.21	33.00%	-16.10%	-17.41%
GELS	GELTEQ LTD	$8.14M	-43.00%	-31.50%	-29.63%	-7,184.60%	0.36	0.27	30.30%	-4,011.90%	-2,834.31%
TXMD	THERAPEUTICSMD INC	$25.93M	1.10%	0.80%	0.71%	0.80%	0.41	2.93	100.00%	10.80%	8.51%
RDHL	REDHILL BIOPHARMA LTD	$0.00	N/A	-46.10%	269.50%	86.10%	-5.17	0.56	64.50%	-97.50%	-110.40%
SHPH	SHUTTLE PHARMACEUTICALS HOLDINGS INC	$1.42M	-476.10%	-253.90%	-674.65%	-20,966.60%	1.54	1.66	N/A	N/A	N/A
SNOA	SONOMA PHARMACEUTICALS INC	$4.21M	-85.90%	-24.20%	-36.68%	-53.30%	2.97	2.88	38.20%	-19.00%	-19.47%
AYTU	AYTU BIOPHARMA INC	$28.01M	-107.20%	-19.70%	-37.96%	-254.40%	7.59	1.16	66.80%	-39.00%	-34.20%
BFRI	BIOFRONTERA INC	$10.13M	-1,139.00%	-52.20%	-60.35%	-120.20%	1.73	1.52	73.70%	-25.30%	-24.12%
APUS	APIMEDS PHARMACEUTICALS US INC	$25.91M	-139.60%	-102.80%	-61.93%	-990.20%	0.13	8.34	N/A	N/A	N/A
CABR	CARING BRANDS INC	$15.47M	N/A	N/A	N/A	N/A	0.22	0.08	N/A	N/A	N/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Mar 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best pharma stocks to buy right now are:

1. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #1 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 5 points higher than the pharmaceutical industry average of 30.

AMRX passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 31.3% over the past year, overperforming other pharmaceutical stocks by 63 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 26.8% from Amneal Pharmaceuticals's current stock price of $11.83.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Teva Pharmaceutical Industries (NYSE:TEVA)

Teva Pharmaceutical Industries (NYSE:TEVA) is the #2 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Teva Pharmaceutical Industries (NYSE:TEVA) is: Value: B, Growth: B, Momentum: B, Sentiment: A, Safety: B, Financials: C, and AI: C.

Teva Pharmaceutical Industries (NYSE:TEVA) has a Due Diligence Score of 24, which is -6 points lower than the pharmaceutical industry average of 30. Although this number is below the industry average, our proven quant model rates TEVA as a "A".

TEVA passed 10 out of 38 due diligence checks and has weak fundamentals. Teva Pharmaceutical Industries has seen its stock return 76.91% over the past year, overperforming other pharmaceutical stocks by 108 percentage points.

Teva Pharmaceutical Industries has an average 1 year price target of $37.38, an upside of 30.09% from Teva Pharmaceutical Industries's current stock price of $28.73.

Teva Pharmaceutical Industries stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Teva Pharmaceutical Industries, 87.5% have issued a Strong Buy rating, 12.5% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top pharmaceutical stock out of 75 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 40, which is 10 points higher than the pharmaceutical industry average of 30.

INDV passed 13 out of 33 due diligence checks and has average fundamentals. Indivior Pharmaceuticals has seen its stock return 202.69% over the past year, overperforming other pharmaceutical stocks by 234 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $44.50, an upside of 51.88% from Indivior Pharmaceuticals's current stock price of $29.30.

Indivior Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Indivior Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Kamada (NASDAQ:KMDA)

Kamada (NASDAQ:KMDA) has an annual dividend yield of N/A, which is N/A percentage points lower than the pharmaceutical industry average of 2.39%.

Kamada's dividend payout ratio of 57.1% indicates that its dividend yield is sustainable for the long-term.

2. Perrigo Co (NYSE:PRGO)

Perrigo Co (NYSE:PRGO) has an annual dividend yield of 6.27%, which is 4 percentage points higher than the pharmaceutical industry average of 2.39%. Perrigo Co's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Perrigo Co's dividend has shown consistent growth over the last 10 years.

Perrigo Co's dividend payout ratio of -11.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Viatris (NASDAQ:VTRS)

Viatris (NASDAQ:VTRS) has an annual dividend yield of 3.64%, which is 1 percentage points higher than the pharmaceutical industry average of 2.39%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of -16% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks down?

Pharmaceutical stocks were down -1.41% in the last day, and up 0.09% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are down.

What are the most undervalued pharmaceutical stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued pharmaceutical stocks right now are:

1. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 33 points higher than the pharmaceutical industry average of 24. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 98.69% in the past year. It has overperformed other stocks in the pharmaceutical industry by 130 percentage points.

2. Bausch Health Companies (NYSE:BHC)

Bausch Health Companies (NYSE:BHC) is the second most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Bausch Health Companies has a valuation score of 29, which is 5 points higher than the pharmaceutical industry average of 24. It passed 2 out of 7 valuation due diligence checks.

Bausch Health Companies's stock has dropped -29.73% in the past year. It has overperformed other stocks in the pharmaceutical industry by 2 percentage points.

3. Collegium Pharmaceutical (NASDAQ:COLL)

Collegium Pharmaceutical (NASDAQ:COLL) is the third most undervalued pharmaceutical stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Collegium Pharmaceutical has a valuation score of 57, which is 33 points higher than the pharmaceutical industry average of 24. It passed 4 out of 7 valuation due diligence checks.

Collegium Pharmaceutical's stock has gained 18.41% in the past year. It has overperformed other stocks in the pharmaceutical industry by 50 percentage points.

Are pharmaceutical stocks a good buy now?

58.97% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 47.51% over the next year.

8.93% of pharmaceutical stocks have a Zen Rating of A (Strong Buy), 30.36% of pharmaceutical stocks are rated B (Buy), 46.43% are rated C (Hold), 10.71% are rated D (Sell), and 3.57% are rated F (Strong Sell).

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is -156.26x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.